Analgesic Effect of Laser Therapy in Children

August 22, 2023 updated by: IRCCS Burlo Garofolo

Analgesic Effect of Laser Therapy in Paediatric Patients Undergoing Tonsillectomy

Pain management after tonsillectomy could be challenging, with different protocols and various outcome depending on individual patient; moreover, odynophagia due to surgery can, in extreme cases, lead to block oral fluid intake, ending in dehydration and thus hospitalization. A small pilot study demonstrated efficacy of photo-biomodulation (PBM) in managing pain after tonsillectomy and it suggests that PBM can be included in clinical practice. The present research aims to confirm and expand the findings from this study, being the first step in including PBM in clinical routine after tonsillectomy. Use of this treatment, which is non-damaging, non-toxic and easy to supply to patients, could greatly improve individual quality of life after a surgical treatment; its use in the clinical practice could represent an advantage for the institute, leading to more patients' satisfaction, due to the lower pain sensation after surgery and quicker recovery time.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Trieste, Italy, 34137
        • Institute for Maternal and Child Health - IRCCS Burlo Garofolo-

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Tonsillectomy or adenotonsillectomy due to apneic chronic snoring and/or obstructive sleep apnea and/or recurrent tonsillitis

Exclusion Criteria:

  1. American Society of Anesthesiologists (ASA) Score > 2
  2. Neuropsychiatric co-morbidity
  3. Pro-hemorrhage coagulation disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Standard care
Experimental: Laser
Laser light will be applied to the surgery site after tonsils excision.
Laser treatment parameters will be two combined wavelength (660 and 970 nm), 3.2 Watt peak power, 320 milliWatt/cm2, 36.8 Joule/cm2 fluency, and 50% frequency, for a total time of 3 minutes for each site

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reduction in pain score, age 3-7 years
Time Frame: After 24 hours
The score is evaluated using the Wong-Baker scale, ranged 0-10. Higher scores correspond to higher levels of pain.
After 24 hours
Reduction in pain score, age 8-18 years
Time Frame: After 24 hours
The score is evaluated using a Visual Analogue Scale (VAS) ranged 0-10. Higher scores correspond to higher levels of pain.
After 24 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reduction in pain score, age 3-7 years
Time Frame: After 4 hours
The score is evaluated using the Wong-Baker scale, ranged 0-10. Higher scores correspond to higher levels of pain.depending on age
After 4 hours
Reduction in pain score, age 3-7 years
Time Frame: After 6 hours
The score is evaluated using the Wong-Baker scale, ranged 0-10. Higher scores correspond to higher levels of pain.
After 6 hours
Reduction in pain score, age 8-18 years
Time Frame: After 4 hours
The score is evaluated using a Visual Analogue Scale (VAS) ranged 0-10. Higher scores correspond to higher levels of pain.
After 4 hours
Reduction in pain score, age 8-18 years
Time Frame: After 6 hours
The score is evaluated using a Visual Analogue Scale (VAS) ranged 0-10. Higher scores correspond to higher levels of pain.
After 6 hours
Frequency of use of pain killer drugs
Time Frame: Within 24 hours
Number of postoperative pain killers drugs administered
Within 24 hours
Reduction in pain score evaluated by parents
Time Frame: 7 days after discharge
Pain evaluated by parents using a Visual Analogue Scale (VAS) ranged 0-10. Higher scores correspond to higher levels of pain.
7 days after discharge
Quality of sleep
Time Frame: 7 days after discharge
The quality of children sleep will be evaluated by parents or caregivers through a questionnaire
7 days after discharge
Mean daily food intake.
Time Frame: 7 days after discharge
The mean daily food intake of children will be evaluated by parents or caregivers through a questionnaire.
7 days after discharge
Frequency of use of pain killer drugs
Time Frame: 7 days after discharge
The number of pain killers drugs administered at home will be measured by parents or caregivers.
7 days after discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Raffaella Sagredini, MD, Institute for Maternal and Child Health IRCCS Burlo Garofolo
  • Principal Investigator: Eva Orzan, MD, Institute for Maternal and Child Health IRCCS Burlo Garofolo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 11, 2021

Primary Completion (Actual)

May 31, 2021

Study Completion (Actual)

May 31, 2021

Study Registration Dates

First Submitted

December 31, 2020

First Submitted That Met QC Criteria

December 31, 2020

First Posted (Actual)

January 5, 2021

Study Record Updates

Last Update Posted (Actual)

August 24, 2023

Last Update Submitted That Met QC Criteria

August 22, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Postoperative

Clinical Trials on Laser therapy

3
Subscribe